Results 211 to 220 of about 129,342 (334)

Denosumab combined with immunotherapy, radiotherapy, and granulocyte-macrophage colony-stimulating factor for the treatment of metastatic nasopharyngeal carcinoma: A case report. [PDF]

World J Clin Oncol
Chen WW, Kong YH, Zhang LY.
europepmc   +1 more source

Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm). [PDF]

Mil Med, 2023
Paine R, Chasse R, Halstead ES, Nfonoyim J, Park DJ, Byun T, Patel B, Molina-Pallete G, Harris ES, Garner F, Simms L, Ahuja S, McManus JL, Roychowdhury DF.   +13 more
europepmc   +1 more source

Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes. [PDF]

, 1992
Simona Zupo, B Perussia, Lucia Baldi, Anna Corcione, Mariella Dono, Manlio Ferrarini, Vito Pistoia   +6 more
openalex   +1 more source

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll‐Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double‐Blind, Placebo‐Controlled Study

ACR Open Rheumatology, Volume 7, Issue 7, July 2025.
Objective There is an unmet need for safe and effective oral treatments for cutaneous lupus erythematosus (CLE). Afimetoran is an investigational, first‐in‐class, orally bioavailable, selective small molecule inhibitor of Toll‐like receptors (TLRs) 7 and 8.
Fareeda Hosein, Stanislav Ignatenko, Kristina D. Chadwick, Lin Zhu, Frédéric Baribaud, Jasmine Saini, Thanh Bach, Urvi Aras, WanYing Zhang, Hazem Karabeber, Michelle Dawes, Melanie Harrison, Leonidas N. Carayannopoulos, Gopal Krishna   +13 more
wiley   +1 more source

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe? [PDF]

Lancet Rheumatol, 2021
Mehta P, Chambers RC, Dagna L.
europepmc   +1 more source

Reconstituted Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor Transduces Growth-Promoting Signals in Mouse NIH 3T3 Cells: Comparison with Signalling in BA/F3 Pro-B Cells [PDF]

, 1993
Sumiko Watanabe, Alice Mui, Akihiko Muto, Jing X. Chen, Kazuhiro Hayashida, Takashi Yokota, Atsushi Miyajima, Ken‐ichi Arai   +7 more
openalex   +1 more source

Oxytocin‐Mediate Modulation of Splenic Immunosuppression in Chronic Social Stress Through Neuroendocrine Pathways

Advanced Science, Volume 12, Issue 25, July 3, 2025.
Chronic social stress elevates oxytocin levels, leading to immunosuppression by enhancing regulatory T‐cell activity and promoting anti‐inflammatory macrophage polarization in the spleen. Blocking oxytocin signaling reverses these effects but worsens stress‐induced behavioral disorders and reduces survival rates. This highlights oxytocin's dual role in
Yi‐Shu Zhang, Hai‐Chao Chen, Jia‐Xin Cao, Si‐Wei Zhou, Yue‐Zhang Ma, Yu‐Hong Jing   +5 more
wiley   +1 more source

Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial. [PDF]

Cancer Immunol Immunother
Yu J, Yin L, Guo W, Wang Q, Liu J, Zhang L, Ye H, Xia J, Xia Y, Wu J, Wang W, Yang Y, Zong D, He X, Wang L, Jiang H.   +15 more
europepmc   +1 more source

Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19. [PDF]

Cell Mol Immunol, 2021
Mu X, Liu K, Li H, Wang FS, Xu R.
europepmc   +1 more source

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma

, 1989
N Phillips, SA Jacobs, Ronald G. Stoller, Martin F. Earle, Donna Przepiorka, RK Shadduck   +5 more
openalex   +1 more source